At the same time, MAZ-silencing VCaP cells exhibited less osteoblastic area of bone tumors, as well as a longer bone tumor burden-free survival time compared with the scramble group (Additional file 2: Figure S2 K-L). The gene discussed is MAZ; the disease is bone neoplasm.